Richard S. Bujaroski

Statistics

Publications

Citations

100

H-Index

Active since

2021

Affiliations

Illawarra Health and Medical Research Institute(Current)

University of Wollongong

University of Otago

Cornell University

Albert Einstein College of Medicine

Richard S. Bujaroski is an author at Illawarra Health and Medical Research Institute specializing in enzyme inhibition, pharmacology, and medicinal chemistry.

ORCID

Publications per year

2021–2023

Publications

An amiloride derivative is active against the F1Fo-ATP synthase and cytochrome bd oxidase of Mycobacterium tuberculosis

Kiel Hards, Chen‐Yi Cheung, Natalie J.E. Waller et al. · Communications Biology · 2022 · 45 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

Screening of 5- and 6-Substituted Amiloride Libraries Identifies Dual-uPA/NHE1 Active and Single Target-Selective Inhibitors

Benjamin J. Buckley, Ashna A. Kumar, Ashraf Aboelela et al. · International Journal of Molecular Sciences · 2021 · 20 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +14

A dual-targeting succinate dehydrogenase and F1Fo-ATP synthase inhibitor rapidly sterilizes replicating and non-replicating Mycobacterium tuberculosis

Cara Adolph, Chen‐Yi Cheung, Matthew B. McNeil et al. · Cell chemical biology · 2023 · 19 citations · Full text

Life Sciences, Medicinal Chemistry, Molecular Biology +13

Systematic evaluation of structure–property relationships and pharmacokinetics in 6-(hetero)aryl-substituted matched pair analogs of amiloride and 5-(N,N-hexamethylene)amiloride

Benjamin J. Buckley, Ashraf Aboelela, Hiwa Majed et al. · Bioorganic & Medicinal Chemistry · 2021 · 16 citations

Pharmacy, Pharmacokinetics, Pharmacology +16

1–4 of 4